Brief: Cresemba Sales In Japan Trigger Second Milestone Payment From Asahi Kasei Pharma To Basilea

Basilea Pharmaceutica AG, Allschwil

24/04/2025 06:17

April 24 (Reuters) - Basilea Pharmaceutica AG Allschwil BSLN.S:

STRONG SALES FOR CRESEMBA® (ISAVUCONAZOLE) IN JAPAN TRIGGER SECOND MILESTONE PAYMENT FROM ASAHI KASEI PHARMA TO BASILEA

BASILEA PHARMACEUTICA -  SALES MILESTONE PAYMENT FROM ITS PARTNER ASAHI KASEI PHARMA (AKP), AMOUNTING TO APPROXIMATELY CHF 1.7 MILLION

Source text: ID:nGNE5qlcMB

Further company coverage: BSLN.S

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))